Skip to content
777 Sourcing.

From the company

Annexon Biosciences is a clinical-stage biopharmaceutical company focused on stopping C1q, the initiating molecule of the classical complement pathway, to treat autoimmune, neurodegenerative, and ophthalmic diseases of the body, brain and eye. It was co-founded by Dr. Ben Barres and Dr. Arnon Rosenthal and has a late-stage clinical pipeline of therapies targeting complement-mediated diseases.

Location: BRISBANE, CA, USFounded: 2011Capabilities: 3Facilities: 1

Products & services offered

Facilities

Headquarters

1400 SIERRA POINT PKWY STE 200, BRISBANE, CA 94005-1808, US

View map

Send your requirements

Quantities, certifications, and timing.

Send your requirements · Supplier responds with a quote · Compare and decide

Similar products and services